Advancing Epidenetic Therapies in Prostate Cancer

$222,977P50FY2008CANIH

Johns Hopkins University, Baltimore MD

Investigators

Roberto Pilicontact

Linked publications, trials & patents

Paper 39578659 Paper 39483900 Paper 39314954 Paper 39269310 Paper 39229204 Paper 39198404 Paper 39040171 Paper 38645078 Paper 38388857 Paper 38112617 Paper 38050147 Paper 37907729 Paper 37850574 Paper 37849074 Paper 37661807 Paper 37409952 Paper 37347938 Paper 37066381 Paper 37012549 Paper 36821396 Paper 36373171 Paper 36372998 Paper 36337169 Paper 36309102 Paper 36194476 Paper 36006048 Paper 35938545 Paper 35908379 Paper 35836303 Paper 35452513 Paper 35333400 Paper 35188986 Paper 35131885 Paper 35104804 Paper 34969655 Paper 34652816 Paper 34533610 Paper 34431104 Paper 34402095 Paper 34341114 Paper 34191807 Paper 34145040 Paper 34062284 Paper 34019793 Paper 33949714 Paper 33724955 Paper 33617332 Paper 33564617 Paper 33511883 Paper 33462368 Paper 33355185 Paper 33328650 Paper 33148676 Paper 33148078 Paper 33024700 Paper 32989253 Paper 32740981 Paper 32723566 Paper 32694154 Paper 32649013 Paper 32587951 Paper 32581009 Paper 32525914 Paper 32506665 Paper 32468444 Paper 32389660 Paper 32304697 Paper 32182119 Paper 32173650 Paper 32031685 Paper 32015231 Paper 31969336 Paper 31915143 Paper 31650100 Paper 31524299 Paper 31503450 Paper 31499027 Paper 31489119 Paper 31361358 Trial NCT00022399 Trial NCT00005639 Patent 9540696 Patent 9297806 Patent 9029340 Patent 9018138 Patent 8551699 Patent 8088621 Patent 7662795 Patent 7645587 Patent 7632643 Patent 7582290 Patent 7579147 Patent 7217421 Patent 7008765 Patent 6043088 Patent 6030793 Patent 6025128 Patent 5874539 Patent 5849509 Patent 5824490

View original record on NIH RePORTER →